Litcius/Paper detail

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Debora Basile, Chloé Broudin, Jean-François Emile, Alexandre Falcoz, Franck Pagès, Laurent Mineur, Jaafar Bennouna, C. Louvet, Pascal Artru, Serge Fratté, François Ghiringhelli, T. André, Valentin Dérangère, Déwi Vernerey, Julien Taı̈eb, M. Svrcek

2022Annals of Oncology42 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHazard ratioPerineural invasionInternal medicineOncologyConfidence intervalColorectal cancerStage (stratigraphy)Overall survivalPost-hoc analysisBiomarkerGastroenterologyCancerChemistryPaleontologyBiologyBiochemistryColorectal Cancer Surgical TreatmentsColorectal Cancer Screening and DetectionGenetic factors in colorectal cancer
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR) | Litcius